Search Count: 8
 |
Optimization Efforts For Identification Of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction Ihhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.32 Å Release Date: 2024-05-22 Classification: PEPTIDE BINDING PROTEIN Ligands: A1LVB, ACT, SO4 |
 |
Optimization Efforts For Identification Of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction (Ppi) Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.42 Å Release Date: 2024-05-22 Classification: PEPTIDE BINDING PROTEIN Ligands: A1LVC, ACT, SO4 |
 |
Methyl And Fluorine Effects In Novel Orally Bioavailable Keap1/Nrf2 Ppi Inhibitor For Treatment Of Chronic Kidney Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2023-06-14 Classification: PEPTIDE BINDING PROTEIN Ligands: SGO, DTT, SO4 |
 |
Methyl And Fluorine Effects In Novel Orally Bioavailable Keap1/Nrf2 Ppi Inhibitor For Treatment Of Chronic Kidney Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2023-06-14 Classification: PEPTIDE BINDING PROTEIN Ligands: SIU, SO4 |
 |
Methyl And Fluorine Effects In Novel Orally Bioavailable Keap1/Nrf2 Ppi Inhibitor For Treatment Of Chronic Kidney Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2023-06-14 Classification: PEPTIDE BINDING PROTEIN Ligands: T6I, SO4 |
 |
Organism: Pseudomonas aeruginosa pao1
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2021-01-13 Classification: HYDROLASE Ligands: ZN, H4L |
 |
Organism: Pseudomonas aeruginosa pao1
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-01-13 Classification: HYDROLASE Ligands: ZN, H4O |
 |
Organism: Pseudomonas aeruginosa pao1
Method: X-RAY DIFFRACTION Resolution:2.07 Å Release Date: 2021-01-13 Classification: HYDROLASE Ligands: ZN, H4R |